Garibaldi Daniel C, Iliff Nicholas T, Grant Michael P, Merbs Shannath L
The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ophthalmic Plast Reconstr Surg. 2007 Nov-Dec;23(6):439-44. doi: 10.1097/IOP.0b013e31815a1235.
To evaluate our initial experience with a porous polyethylene implant with embedded titanium in orbital reconstruction.
A retrospective review of the charts was performed for patients receiving at least 1 orbital porous polyethylene implant with embedded titanium from October 2004 through April 2006. Patient demographics, implant type and size, method of fixation, postoperative complications, and length of follow-up were recorded.
One-hundred six patients received at least one embedded titanium implant (80 men, 26 women). Age ranged from 3 years to 85 years (mean, 31 years). Indications included orbital fracture repair (102 patients), correction of enophthalmos (3 patients), and reconstruction after tumor resection (1 patient). The average floor implant used was 22.3 mm wide by 27.9 mm long. The average medial wall implant was 13.6 mm tall by 22 mm long. Implants were fixated with 1 or 2 microscrews in 75 patients (70.8%) and placed without fixation in 31 patients (29.2%). Four postoperative complications were noted: a retrobulbar hemorrhage on postoperative day 3 that resolved without sequelae, a vertical overcorrection requiring removal of the implant, a transient oculomotor disturbance, and a screw placed in proximity to the infraorbital nerve canal resulting in hypesthesia and chronic pain that required removal of the screw. In the 3 complications potentially related to the implant, the embedded titanium allowed postoperative implant visualization and guided subsequent management. No implant extrusions or postoperative infections were noted.
Porous polyethylene implants with embedded titanium provide a new alternative to alloplastic implant materials for orbital reconstruction with a profile that combines several advantages of porous polyethylene and titanium implants.
评估我们使用含嵌入式钛的多孔聚乙烯植入物进行眼眶重建的初步经验。
对2004年10月至2006年4月期间接受至少1次含嵌入式钛的眼眶多孔聚乙烯植入物的患者病历进行回顾性研究。记录患者人口统计学资料、植入物类型和尺寸、固定方法、术后并发症及随访时间。
106例患者接受了至少1次嵌入式钛植入物(80例男性,26例女性)。年龄范围为3岁至85岁(平均31岁)。适应证包括眼眶骨折修复(102例患者)、眼球内陷矫正(3例患者)及肿瘤切除术后重建(1例患者)。所使用的平均眶底植入物宽22.3 mm,长27.9 mm。平均眶内壁植入物高13.6 mm,长22 mm。75例患者(70.8%)使用1枚或2枚微螺钉固定植入物,31例患者(29.2%)未进行固定直接植入。记录到4例术后并发症:术后第3天发生球后出血,自行消退无后遗症;垂直性过度矫正,需取出植入物;短暂性动眼神经功能障碍;1枚螺钉靠近眶下神经管,导致感觉减退和慢性疼痛,需取出螺钉。在3例可能与植入物相关的并发症中,嵌入式钛使术后植入物可视化并指导了后续处理。未发现植入物外露或术后感染。
含嵌入式钛的多孔聚乙烯植入物为眼眶重建的异体植入材料提供了一种新的选择,其兼具多孔聚乙烯和钛植入物的多种优点。